CVS Health Corp (CVS)
65.32
-1.01 (-1.52%)
CVS Health Corp is a diversified healthcare company that operates a vast network of retail pharmacies, providing prescription medications, over-the-counter products, and health and wellness services
In addition to its retail operations, CVS Health also offers pharmacy benefit management services, helping manage prescription drug costs for businesses and health plans. The company is involved in providing health insurance and health services through its various divisions, including a growing presence in digital health solutions and immunization services. By integrating pharmacy services with healthcare delivery, CVS Health aims to enhance patient care and improve health outcomes across the communities it serves.

CVS Health has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.4%. The stock now trades at $65.60, marking a 15.2% gain. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Via StockStory · March 10, 2025

Speculation over an impending reverse merger, a Phase 2 trial announcement, comments about upcoming cancer screening tests, a Medicare business deal, and an obesity drug partnership sparked buzz among Stocktwits users for the week ended March 7, 2025.
Via Stocktwits · March 10, 2025

Via Benzinga · March 10, 2025

Via Benzinga · March 6, 2025

Via Benzinga · February 26, 2025

Via Benzinga · February 21, 2025

Via The Motley Fool · February 18, 2025

Via The Motley Fool · March 1, 2025

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US.
Via Talk Markets · February 25, 2025

Healthcare stocks took a tumble in 2024 as rising medical costs did a number on margins and profitability, but 2025 may be the year they rebound.
Via MarketBeat · February 24, 2025

After a stellar 2024, the S&P 500 has been on a bullish trend this year, too.
Via Talk Markets · February 21, 2025

Curious about the S&P500 stocks that are showing activity before the opening bell on Friday?
Via Chartmill · February 21, 2025

Via Talk Markets · February 18, 2025

Via Benzinga · February 13, 2025

The Justice Department is investigating UnitedHealth's Medicare billing practices, focusing on diagnoses that led to higher federal payments. The probe follows reports that the company received billions for questionable diagnoses in its Medicare Advantage plans.
Via Benzinga · February 21, 2025

Via The Motley Fool · February 19, 2025

Humana is the second largest health insurance provider of Medicare Advantage (MA) plans sounding the alarms of rising medical costs but will now cut 10%
Via MarketBeat · February 20, 2025

Via Benzinga · February 18, 2025

In the last week, these 13 large-cap stocks were top performers. Are they in your portfolio? HIMS, AUR, APP, SMCI, TEM, DKNG, INTC, MNDY, BROS, CVS, BABA, AAPL, ABNB.
Via Benzinga · February 16, 2025

Via Benzinga · February 14, 2025

Get insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill · February 13, 2025

Analysts largely believe that the company’s Aetna insurance business is set to rebound and its margins will recover soon.
Via Stocktwits · February 13, 2025